Viemed Healthcare, Inc. (VMD) Earnings History
Turnaround12 years of earnings data (2014–2025) · Recovering earnings after a multi-year decline
Loading earnings history...
Viemed Healthcare, Inc. (VMD) Earnings Overview
As of June 29, 2026, Viemed Healthcare, Inc. (VMD) reported trailing twelve-month net income of $15M, reflecting +32.1% year-over-year growth. The company earned $0.37 per diluted share over the past four quarters, with a net profit margin of 5.5%.
Looking at the long-term picture, VMD's 5-year EPS compound annual growth rate (CAGR) stands at -14.7%, signaling declining earnings. The company achieved its highest annual net income of $32M in fiscal 2020.
Viemed Healthcare, Inc. maintains positive profitability with a gross margin of 57.5%, operating margin of 7.7%, and net margin of 5.5%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including LINC ($22M net income, 3.9% margin), BRT (-$12M net income, -12.3% margin), EHAB (-$3M net income, -0.4% margin), VMD has outperformed on profitability metrics. Compare VMD vs LINC →
VMD Earnings vs Peers
Earnings metrics vs comparable public companies
VMD Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $15M | +32.6% | $21M | $0.37 | 5.5% | 7.7% |
| 2024 | $11M | +10.0% | $18M | $0.28 | 5.0% | 8.0% |
| 2023 | $10M | +64.6% | $14M | $0.25 | 5.6% | 7.8% |
| 2022 | $6M | -31.8% | $8M | $0.15 | 4.5% | 5.9% |
| 2021 | $9M | -71.1% | $12M | $0.22 | 7.8% | 9.9% |
| 2020 | $32M | +269.9% | $27M | $0.82 | 24.0% | 20.4% |
| 2019 | $9M | -16.2% | $9M | $0.22 | 10.6% | 11.0% |
| 2018 | $10M | +24.5% | $17M | $0.26 | 15.6% | 26.1% |
| 2017 | $8M | +565.8% | $9M | $0.22 | 17.4% | 18.8% |
| 2016 | $1M | -86.2% | $383,000 | $0.03 | 3.9% | 1.2% |
| 2015 | $9M | -5.6% | $10M | $1.49 | 25.8% | 29.0% |
| 2014 | $9M | - | $9M | $1.58 | 40.6% | 40.7% |
Download Data
Export VMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VMD — Frequently Asked Questions
Quick answers to the most common questions about buying VMD stock.
What is VMD earnings per share (EPS)?
VMD trailing twelve-month (TTM) diluted EPS is $0.37, reflecting +32.1% year-over-year growth. The 5-year EPS CAGR is -14.7%. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is Viemed Healthcare, Inc.'s net income?
Viemed Healthcare, Inc. (VMD) trailing twelve-month net income is $15M as of 2025. Earnings grew +32.1% year-over-year. Viemed Healthcare, Inc. has been profitable for 12 consecutive years.
Is VMD profitable?
Yes, VMD is profitable with a TTM net income of $15M and a net profit margin of +5.5%. Viemed Healthcare, Inc. has generated profits for 12 consecutive years.
What is VMD's earnings growth rate?
VMD compound annual EPS growth rates (CAGR): 1-Year: +32.1%, 3-Year: +35.1%, 5-Year: -14.7%, 10-Year: -13.0%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are VMD's profit margins?
Viemed Healthcare, Inc. net profit margin is +5.5%, operating margin is +7.7%, and gross margin is +57.5%. Margins are within a typical range for the sector. Return on Equity is +10.8%.
Is VMD growing earnings?
Yes, VMD earnings are accelerating — EPS growth of +32.1% exceeds the 5-year CAGR of -14.7%. TTM net income reached $15M. Earnings momentum is strengthening.
What was VMD's best earnings year?
Viemed Healthcare, Inc.'s highest annual net income on record is $32M, achieved in fiscal year 2020. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were VMD's earnings last quarter?
VMD's most recent reported quarter was Q1 2026. Net income was $3M with diluted EPS of $0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.